SYFOVRE™ (pegcetacoplan injection) has been approved by the U.S. Food & Drug Administration (FDA) for people with geographic atrophy (GA) secondary to age-related macular degeneration (AMD), a leading cause of devastating central vision loss in people over 55 in developed countries. The newly approved therapy is the first ever approved by the FDA for GA. …
SYFOVRE, for the Treatment of Dry Macular Degeneration Read More »
Blue light from electronic screens is not making you blind. A recently released study has been creating both concern in the public and alarmist headlines from news outlets worldwide. But experts are cautioning that the news reports are leaping to unfounded conclusions about the potential effects of blue light on the eye. This laboratory research is not a reason …
No, Blue Light From Your Smartphone Is Not Blinding You Read More »
New over-the-counter eye whitening drops may have some advantages over older drops, such as Visine, but ophthalmologists caution that any whitening drops can mask symptoms of serious disease. Lumify was approved by the U.S. Food and Drug Administration in December 2017, and started appearing on store shelves in mid-2018. Ads for Lumify state the drops can be …
New Over-the-Counter Eye-Whitening Drop Hits Store Shelves Read More »
* All indicated fields must be completed.
Please include non-medical questions and correspondence only.
